Concepedia

James W. Shaw

JW

60

Publications

9.9K

Citations

33

H-Index

1926

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

University of Illinois Chicago

University of Arizona

University of Alberta

Northwestern University

James W. Shaw is an author at Bristol-Myers Squibb (United States) specializing in medicine, public health, and health policy.

ORCID

Top concepts

Publications per year

1926–2025

60

Publications

60

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 4.9K citations · Full text

US Valuation of the EQ-5D Health States

James W. Shaw, Jeffrey Johnson, Stephen Joel Coons · Medical Care · 2005 · 1.3K citations

Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Kevin J. Harrington, Robert L. Ferris, George R. Blumenschein et al. · The Lancet Oncology · 2017 · 417 citations · Full text

, , +11

Self-Reported Health Status of the General Adult U.S. Population as Assessed by the EQ-5D and Health Utilities Index

Nan Luo, Jeffrey Johnson, James W. Shaw et al. · Medical Care · 2005 · 389 citations

United States Valuation of EQ-5D-5L Health States Using an International Protocol

A. Simon Pickard, Ernest H. Law, Ruixuan Jiang et al. · Value in Health · 2019 · 360 citations · Full text

Rows per page

1–5 of 60